Stoke Therapeutics (STOK) PT Raised to $36 at Canaccord Genuity Jan 5, 2026 04:24AM
Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference Aug 6, 2025 04:30PM
Stoke Therapeutics (STOK) PT Lowered to $20 at Canaccord Genuity May 7, 2024 06:21AM
Stoke Therapeutics (STOK) PT Raised to $21 at Canaccord Genuity Mar 26, 2024 09:54AM
Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference Aug 2, 2023 08:00AM


Aug 3, 2021 08:00AM Stoke Therapeutics to Present at Upcoming Investor Conferences in August
Nov 24, 2020 04:01PM Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 20, 2020 05:54AM Stoke Therapeutics Inc. (STOK) Prices 2.5M Share Common Offering at $39/Sh
Nov 19, 2020 07:00PM Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
Nov 18, 2020 04:02PM Stoke Therapeutics Inc. (STOK) Announces 2.5M Share Proposed Public Offering
Nov 18, 2020 04:02PM Stoke Therapeutics Announces Proposed Public Offering
Aug 4, 2020 07:30AM Stoke Therapeutics to Present at Upcoming Investor Conferences in August
Aug 1, 2019 08:00AM Stoke Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
Jul 15, 2019 07:36AM UPDATE: Canaccord Genuity Starts Stoke Therapeutics (STOK) at Buy
Jun 21, 2019 04:01PM Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 19, 2019 10:49AM Stoke Therapeutics (STOK) IPO Opens 51% Higher
Jun 19, 2019 05:52AM Stoke Therapeutics, Inc. (STOK) Prices 7.89M Share IPO at $18/Sh
Jun 18, 2019 06:45PM Stoke Therapeutics Announces Pricing of Initial Public Offering